This is a summary of recommendations and resources for COVID-19 therapeutics adapted from information provided by the California Department of Public Health (CDPH). Because COVID-19 therapeutics are a rapidly changing area of pandemic response, we encourage all providers to regularly check for updates on variant resistance, eligible populations, and treatment guidelines.
Available Outpatient Therapies at Each Disease Stage
The red circle indicates: not effective against Omicron and as of 4/5/22 no longer authorized for use in any U.S region.
ORAL ANTIVIRAL TREATMENTS OUTPATIENT TREATMENT OPTIONS FOR COVID-19:
The FDA authorized two oral antivirals, Pfizer's Paxlovid and Merck's molnupiravir, for the treatment of COVID-19 in certain patients.
Pre Exposure Prophylaxis
-
The FDA authorized Evusheld for the pre-exposure prophylaxis of COVID-19 in certain adults and pediatric individuals (12 years of age and older weighing at least 88 lbs or 40 kg)
Monoclonal Antibody Treatments
COVID-19 monoclonal antibody therapeutics (mAb) are available for people ages 12 years or older who:
-
Have tested positive for COVID-19 and have had symptoms for 10 days or less
-
Are at high risk of becoming seriously ill, including those who have been recently exposed to someone who tested positive for COVID-19.
LOCATIONS IN THE CITY OF LONG BEACH OFFERING PRE-EXPOSURE PROPHYLAXIS:
Optum-Willow Urgent Care |
Memorial Care Long Beach Medical Center |
LOCATIONS IN THE CITY OF LONG BEACH OFFERING ORAL ANTIVIRALS
AARCMC - Long Beach |
Atlantic Drugs |
Aviva Pharmacy |
Carbon Health |
Los Angeles County Long Beach CHC |
Malek Medicine |
Memorial Care Long Beach Medical Center |
Panacea Healthcare |
Pavilions Pharmacy |
Rite Aid #05525 |
Southern California Medical Center (SCMC) |
Spring Park Pharmacy |
The Children's Clinic - SMTF |
UrgentCare3D |
Vons Pharmacy |
Vons Pharmacy |
Walgreens #5650 |
Walgreens #7244 |
Young-Jae Kwon MD |
LOCATIONS IN THE CITY OF LONG BEACH OFFERING MONOCLONAL ANTIBODY INFUSIONS:
College Medical Center |
Dignity Health – St. Mary Medical Center |
Memorial Care Long Beach Medical Center |
TEST TO TREAT
The Biden-Harris Administration launched a nationwide Test to Treat initiative, that has been expanded to give individuals an important way to rapidly access free lifesaving treatment for COVID-19. In this program, people are able to get tested and – if they are positive and treatments are appropriate for them – receive a prescription from a health care provider, and have their prescription filled all in one location. These “One-Stop Test to Treat” locations are available at hundreds of locations nationwide, including pharmacy-based clinics, federally-qualified community health centers (FQHCs), and long-term care facilities. People will also continue to be able to be tested and treated by their own health care providers who can appropriately prescribe these oral antivirals at locations where they are being distributed.
FACT SHEET: COVID-19 TEST TO TREAT
Test to Treat Locations in the City of Long Beach: |
CVS Pharmacy #8876 |
Healthcare in Action |
The Children's Clinic - SMTF |
Worksite Labs - Long Beach |
To search by zip code for US locations (including Test to Treat) that offer oral medication, use the federal Test to Treat Locator.
LOS ANGELES COUNTY TELEHEALTH LINE
The City, in partnership with Heathvana, the City's test results delivery partner, will make it easier for people to receive COVID-19 medications after contracting the virus.
This will provide equitable and timely access to treatment, improving health outcomes for all, especially those with less access to a primary care provider and those who are at higher risk. PCR test results through the Healthvana platform will now include a clickable button that will link to information about treatment options and allow people to request antivirals for free (if applicable) through Los Angeles County’s telehealth phone line at 1-833-540-0473.
This new feature, built into Healthvana’s test results, will make it easier for the community to receive and benefit from the antivirals Paxlovid and Molnupiravir, which should be taken within five days of symptom onset. Both medications reduce the ability of the virus to multiply and spread through the body, reducing the risk of hospitalization.
Additionally, those who receive a positive test result from an at-home test or from a rapid antigen test administered at one of the City-run sites can also call 1-833-540-0473 for treatment assessment.
People can contact telehealth services seven days a week from 8 a.m. to 8:30 p.m. Call center staff will answer questions and connect patients to services as needed. These antiviral treatments are free, do not require the person to have a primary care physician and are available regardless of immigration status. The treatment can be prescribed through the telehealth phone line and can be delivered to the patient’s door the very next day.
COVID-19 Treatment & Telehealth
LOCATIONS IN THE SURROUNDING AREA SPONSORED BY THE STATE OFFERING MONOCLONAL ANTIBODY INFUSIONS:
Hawaiian Gardens MAB & Testing Center |
ContinuEM Urgent Care |
BEST RESOURCES FOR UP-TO-DATE INFORMATION AND LOCATIONS:
-
Therapeutic Locator in Los Angeles County: Procuring Medications for Your Patients
-
Therapeutic Locator (HHS) outside of Los Angeles County: COVID-19 Therapeutics Locator (arcgis.com)
-
NIH Treatment Guidelines: COVID-19 Treatment Guidelines (nih.gov)
-
ASPR/HHS website: COVID-19 Therapeutics | HHS/ASPR
-
Side-by-side comparison table for specific drugs: Side-by-Side Overview of Outpatient Therapies Authorized for Treatment of Mild-Moderate COVID-19 (hhs.gov)
-
CDPH COVID-19 Treatments site (information for patients and providers): COVID-19 Treatments (ca.gov)
-
CDPH COVID-19 Treatment and Telehealth: COVID-19 Treatment and Telehealth
- CDPH COVID-19 Treatment Resources: COVID-19 Treatment Resources for Healthcare Providers
HEALTHCARE PROVIDER FACT SHEETS:
-
Pre exposure: Evusheld
-
Post exposure:Paxlovid, Sotrovimab, Bebtelovimab, Remdesivir (here for patients <12 years of age), Molnupiravir,
-
Due to increases in Omicron BA.2 sub-variant in California, the FDA updated the sotrovimab EUA on 3/30/2022 and the drug is no longer authorized for use in California.
If you have additional questions, please email covid19vaccine@longbeach.gov or call 562.570.INFO.